CVS » Topics » (Revised - Unaudited)

This excerpt taken from the CVS 8-K filed Feb 25, 2005.

(Revised - Unaudited)

 

     Fiscal Year Ended

 

In millions


  

January 1,

2005

(52 weeks)


   

January 3,

2004

(53 weeks)


 
    

Reconciliation of net earnings to net cash provided by operating activities:

                

Net earnings

   $ 918.8     $ 847.3  

Adjustments required to reconcile net earnings to net cash provided by operating activities:

                

Depreciation and amortization

     496.8       341.7  

Deferred income taxes and other noncash items

     (23.6 )     41.1  

Change in operating assets and liabilities, providing/(requiring) cash, net of effects from acquisitions:

                

Accounts receivable, net

     (48.4 )     (311.1 )

Inventories

     (509.8 )     2.1  

Other current assets

     35.7       (3.0 )

Other assets

     8.5       (0.4 )

Accounts payable

     109.4       (41.5 )

Accrued expenses

     (144.2 )     116.5  

Other long-term liabilities

     71.0       (23.8 )
    


 


Net cash provided by operating activities

     914.2       968.9  
    


 



(1) During the fourth quarter of fiscal 2004, the Company changed its method of reporting cash flows under Statement of Financial Accounting Standards (“SFAS”) No. 95, “Statement of Cash Flows,” from the indirect method to the direct method. As part of a continuing effort to make its consolidated financial statements more transparent, the Company believes that the direct method, which is the preferred method under SFAS No. 95, will provide additional useful information about its business to investors and other interested parties. In connection with implementing this change, the consolidated statements of cash flows for all prior periods presented have been changed to the direct method. This change does not affect the consolidated statements of operations, consolidated balance sheets or consolidated statements of shareholders’ equity.
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki